Gelone Steven P. 4
4 · Nabriva Therapeutics plc · Filed Aug 3, 2022
Insider Transaction Report
Form 4
Gelone Steven P.
Chief Development Officer
Transactions
- Tax Payment
Ordinary Shares
2022-07-31$0.18/sh−61$11→ 361,550 total
Footnotes (1)
- [F1]These ordinary shares were withheld by the Issuer in order to satisfy tax withholding obligations upon the vesting of certain restricted share units.